SHANNON SOUTHWICK: Open Payments
NPI 1851768105 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,040 in 174 payments from 32 companies in 2025. Trend: 2023 $7,180 · 2024 $9,445 · 2025 $9,040
Speaker / faculty: $4,800Food & beverage: $3,676Travel & lodging: $452Education: $112
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $5,421 |
| Daiichi Sankyo Inc. | 55 | $778 |
| Novartis Pharmaceuticals Corporation | 18 | $431 |
| Exelixis Inc. | 11 | $427 |
| Gilead Sciences, Inc. | 9 | $231 |
| Merck Sharp & Dohme LLC | 8 | $209 |
| Janssen Biotech, Inc. | 12 | $209 |
| Regeneron Healthcare Solutions, Inc. | 3 | $160 |
| PFIZER INC. | 8 | $142 |
| Adaptive Biotechnologies Corporation | 2 | $140 |
Products named: LYNPARZA, Enhertu, CABOMETYX, Trodelvy, SCEMBLIX, KEYTRUDA, clonoSEQ, DATROWAY.
Industry payments across NV — which companies pay providers there.
